Birmingham and Solihull STP - Heart failure Birmingham South Birmingham Cross Indicator National Solihull CCG and Central CCG City CCG Heart failure QOF Prevalence (all ages) 0.6% 0.7% 0.7% 0.8% (2016/17) Heart failure admissions per 100,000 (all 271.3 234.1 127.5 153.8 ages) (2004/05-2015/16) Diagnosis confirmed by ECG/ Specialist 92.0% 91.4% 92.6% 91.1% assessment (2016/17) The % of patients with Heart failure due to left 82.2% 82.1% 87.2% ventricular dysfunction (LVD) who are currently 83.9% treated with an ACE inhibitor (ACE-I) or angiotensin receptor blocker (ARB)* (2016/17)
Birmingham and Solihull STP - Heart failure Indicator National Birmingham South and Central CCG Birmingham Cross City CCG Solihull CCG Heart failure QOF Prevalence (all ages) (2016/17) 0.8% 0.6% 0.7% 0.7% Heart failure admissions per 100,000 (all ages) (2004/05-2015/16) 153.8 271.3 234.1 127.5 Diagnosis confirmed by ECG/ Specialist assessment (2016/17) 91.1% 92.0% 91.4% 92.6% The % of patients with Heart failure due to left ventricular dysfunction (LVD) who are currently treated with an ACE inhibitor (ACE-I) or angiotensin receptor blocker (ARB)* (2016/17) 83.9% 82.2% 82.1% 87.2%
FINALISED-STP-Birmingham-and-Solihull-PACK-V1-Jan-2018.docx